Related Experiment Videos
[Beta-adrenergic receptor blockers in clinical practice].
1Debreceni Egyetem, Orvos- és Egészségtudományi Centrum, Altalános Orvostudományi Kar, Kardiológiai Intézet. iczuriga@jaguar.dote.hu
Orvosi Hetilap
|November 13, 2004
Summary
Beta-adrenergic receptor antagonists, or beta-blockers, revolutionized cardiovascular therapy. This review details their evolution and current clinical uses in treating heart conditions.
Area of Science:
- Cardiovascular Pharmacology
- Pharmacotherapy
- Adrenergic Receptor Antagonists
Context:
- The discovery of the beta receptor system and beta-adrenergic receptor antagonists marked a significant advancement in cardiovascular pharmacotherapy.
- Beta-blockers, initially non-cardioselective like propranolol, evolved into second-generation (beta1 selective) and third-generation (vasodilator properties) agents.
- These drugs have been integral to cardiovascular therapy for decades, expanding their applications over time.
Purpose:
- To review the historical development of beta-adrenergic receptor antagonists.
- To summarize the current clinical indications for beta-blockers in cardiovascular medicine.
- To discuss practical considerations for the use of beta-blockers.
Summary:
- Beta-blockers were first used for angina pectoris and arrhythmias, later expanding to hypertension treatment.
- Their application has progressed to include conditions like congestive heart failure, previously a contraindication.
- This review consolidates recent clinical uses and practical aspects of beta-blocker therapy.
Impact:
- Beta-blockers represent a cornerstone of modern cardiovascular pharmacotherapy.
- The evolution of beta-blockers has led to improved treatment strategies for various heart diseases.
- Understanding their indications and practical use is crucial for effective patient management.